Scarica l'app Stockscreener
0.00
100.00%
-2.99
Precedente Chiudi:
$2.99
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$10.05M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$5.84
Entero Therapeutics Inc Stock (ENTO) Company Profile
Nome
Entero Therapeutics Inc
Settore
Industria
Telefono
561-589-7020
Indirizzo
777 YAMATO ROAD, BOCA RATON
Confronta ENTO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
0.00 | 10.05M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Entero Therapeutics Inc Borsa (ENTO) Ultime notizie
What valuation multiples suggest for Entero Therapeutics Inc. stockJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - Улправда
ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer - Treasure Coast News
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy - Lubbock Avalanche-Journal
What drives Entero Therapeutics Inc stock priceVolume Profile Analysis & Low Risk Trading Alerts - earlytimes.in
Entero Regains Nasdaq Compliance With Grid AI Acquisition - The News Leader | Staunton, VA
GridAI Technologies announces board changes and rebranding - MSN
Entero Therapeutics Inc Stock Analysis and ForecastDividend Aristocrats List & Exceptional Growth Portfolio - earlytimes.in
Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX" - Lohud
GridAI Technologies Corp. Announces Appointment of Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc - The Florida Times-Union
GridAI Technologies Announces Board Changes and Rebranding - The Globe and Mail
GridAI Technologies Corp. Announces Board and Committee Changes - marketscreener.com
GridAI Technologies Corp. Appoints Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc - marketscreener.com
GridAI Technologies (NASDAQ: GRDX) taps Marshall Chapin to lead AI data-center grid unit - Stock Titan
Entero Therapeutics Stock Jumps After Company Rebrands As GridAI Technologies Corp. - MSN
GRDXGridAI Technologies Corp Stock Price and Quote - Finviz
Entero Therapeutics, Inc. (ENTO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Entero Therapeutics Stock Gains 5% Ahead Of Name Change To GridAI - Nasdaq
Entero Therapeutics (ENTO) to Rebrand as GridAI (GRDX) Technologies - GuruFocus
Entero Therapeutics to Change Name to GridAI Technologies - marketscreener.com
Entero Therapeutics stock rises ahead of name change to GridAI By Investing.com - Investing.com UK
Entero Therapeutics stock rises ahead of name change to GridAI - Investing.com India
Entero Therapeutics Inc Azioni (ENTO) Dati Finanziari
Non sono disponibili dati finanziari per Entero Therapeutics Inc (ENTO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):